| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥467.1B | ¥433.8B | +7.7% |
| Operating Income | ¥49.9B | ¥40.1B | +24.5% |
| Ordinary Income | ¥62.3B | ¥50.5B | +23.4% |
| Net Income | ¥39.6B | ¥41.0B | -3.2% |
| ROE | 2.6% | 2.7% | - |
FY2026 Q1 results: Revenue 467.1B yen (YoY +7.7%), Operating Income 49.9B yen (+24.5%), Ordinary Income 62.3B yen (+23.4%), Net Income 39.6B yen (-3.2%). The quarter demonstrated strong top-line expansion and operating leverage improvement, with gross profit margin rising to 22.4% from prior year's 22.0%. Operating margin improved 1.8pt to 10.7% from 9.2% YoY, reflecting improved segment profitability particularly in the core Agricultural Chemicals segment. However, net income declined slightly despite operating profit growth, primarily due to increased tax burden (effective tax rate 36.2% vs 18.7% prior year). The company maintained its full-year guidance of revenue 1620.0B yen (-5.0% YoY), operating income 72.0B yen (-31.9% YoY), indicating Q1 significantly outperformed typical seasonal patterns.
Revenue growth of +7.7% was driven by strong performance in the core Agricultural Chemicals and Agriculture-Related segment, which generated 377.9B yen (+9.1% YoY) and represented 80.9% of total revenue. The Chemicals segment contributed 66.7B yen (+12.0% YoY), while Other segment revenue declined to 31.9B yen (-16.4% YoY). Cost of sales increased 8.4% to 362.6B yen, growing faster than revenue, yet gross profit margin improved 0.4pt to 22.4% due to pricing power and product mix effects. SG&A expenses of 54.5B yen decreased 1.8% YoY, contributing to operating leverage with the SG&A ratio improving 1.1pt to 11.7% from 12.8%. Operating income surged 24.5% to 49.9B yen, benefiting from top-line momentum and cost discipline. Non-operating income contributed significantly at 15.4B yen, including equity method income of 13.7B yen (compared to 8.9B yen prior year), which boosted ordinary income to 62.3B yen (+23.4%). The sharp increase in equity method income represented approximately 55% of the difference between operating and ordinary income. However, income tax expense more than doubled to 22.5B yen from 9.4B yen prior year, raising the effective tax rate from 18.7% to 36.2%, which compressed net income to 39.6B yen (-3.2% YoY). This represents a revenue up/operating profit up pattern, with the net income decline attributable to higher tax burden rather than operational deterioration.
Agricultural Chemicals and Agriculture-Related segment generated revenue of 377.9B yen (+9.1% YoY) with operating income of 46.0B yen (+27.7% YoY), achieving a segment margin of 12.2% (up from 10.4% prior year). This segment represents the core business with 80.9% revenue share and demonstrated the strongest profitability improvement. Chemicals segment recorded revenue of 66.7B yen (+12.0% YoY) with operating income of 6.7B yen (+20.4% YoY), maintaining a segment margin of 10.1% (compared to 9.4% prior year). Other segments generated revenue of 31.9B yen (-16.4% YoY) with operating income of 2.0B yen (-24.8% YoY), showing a margin compression to 6.2% from 7.4% prior year. The Agricultural Chemicals segment's margin expansion of 1.8pt was the primary driver of consolidated operating margin improvement, while the Other segments experienced both revenue contraction and margin deterioration, reflecting business portfolio optimization or market headwinds in non-core operations.
[Profitability] ROE of 2.6% remains below industry standards despite improved operating performance, reflecting low capital efficiency with net profit margin of 8.5%, asset turnover of 0.179x, and financial leverage of 1.69x. Operating margin improved significantly to 10.7% from 9.2% YoY (+1.5pt), driven by the Agricultural Chemicals segment achieving 12.2% margin. Gross profit margin of 22.4% (+0.4pt YoY) indicates modest pricing power or favorable product mix. [Cash Quality] Cash and deposits increased to 300.0B yen from 219.8B yen (+36.5% YoY), providing solid liquidity with short-term debt coverage of 0.60x against short-term borrowings of 502.5B yen. The substantial cash accumulation alongside increased short-term borrowings suggests working capital buildup rather than operational cash generation. [Investment Efficiency] Asset turnover of 0.179x (annualized basis) remains low, constrained by elevated inventory levels of 580.7B yen (22.3% of total assets) and investment securities of 409.4B yen (15.7% of total assets). Inventory turnover deterioration reflects extended working capital cycles. [Financial Health] Equity ratio of 59.1% (down from 60.9% prior year) remains healthy, with current ratio of 197.7% and debt-to-equity ratio of 0.69x indicating conservative capital structure. However, short-term borrowings increased 36.6% to 502.5B yen, representing 79.4% of total interest-bearing debt, creating refinancing concentration risk despite adequate overall liquidity.
Cash and deposits increased 80.2B yen YoY to 300.0B yen, representing a 36.5% expansion that coincided with a 134.7B yen increase in short-term borrowings to 502.5B yen. This suggests the cash accumulation primarily reflects debt financing rather than organic cash generation. Working capital efficiency deteriorated with inventories rising 8.1B yen to 580.7B yen and accounts receivable increasing 72.5B yen to 462.1B yen, indicating extended cash conversion cycles. Accounts payable increased 31.0B yen to 261.4B yen, reflecting supplier credit utilization but insufficient to offset working capital buildup. Investment securities expanded 22.9B yen to 409.4B yen, representing continued investment activity. The cash-to-short-term-debt ratio of 0.60x indicates the company maintains debt-financed liquidity rather than self-sustaining cash generation, requiring attention to refinancing sustainability. Total assets grew 5.1% to 2609.1B yen while equity increased modestly by 2.1% to 1542.8B yen, resulting in slightly elevated leverage despite maintaining a conservative equity ratio of 59.1%.
Ordinary income of 62.3B yen versus operating income of 49.9B yen reflects net non-operating contribution of 12.4B yen, primarily consisting of equity method gains of 13.7B yen which increased 55% YoY. Non-operating income represents 3.3% of revenue, comprising equity method income (13.7B yen), dividend income (1.0B yen), and FX gains (1.2B yen), partially offset by interest expense (1.6B yen) and FX losses (1.3B yen). The significant equity method income contribution indicates earnings reliance on associated company performance rather than core operations. The effective tax rate of 36.2% substantially exceeded the prior year's 18.7%, suggesting normalization from previous tax benefits or one-time adjustments. The gap between comprehensive income of 48.8B yen and net income of 39.6B yen reflects 9.2B yen of other comprehensive income, including valuation gains on securities (3.9B yen) and share of OCI from equity method investments (5.9B yen), offset by FX translation adjustments (-0.6B yen). While operating cash flow data is unavailable for quarterly reporting, the substantial working capital buildup in inventories and receivables raises concerns about cash earnings quality despite reported profit growth.
Full-year guidance progress shows revenue at 28.8% (467.1B yen actual vs 1620.0B yen forecast), operating income at 69.3% (49.9B yen vs 72.0B yen), and ordinary income at 57.1% (62.3B yen vs 109.0B yen) against Q1 standard benchmark of 25%. Revenue and operating income progress rates significantly exceed seasonal norms, while ordinary income shows even stronger outperformance, indicating aggressive backend weighting in company forecasts. The company maintained its full-year guidance without revision despite Q1 outperformance, projecting full-year revenue decline of -5.0% and operating income decline of -31.9%. This implies substantial sequential deterioration expected in Q2-Q4, with implied remaining nine-month revenue of 1152.9B yen representing -11.3% YoY decline and operating income of 22.1B yen implying -72.5% decline. The significant forecast conservatism or expected seasonal headwinds warrant clarification. Net income guidance of 64.0B yen implies 10.0% annual decline despite Q1 showing only -3.2% decline, suggesting either one-time Q1 tax benefits or expected earnings pressure. The annual dividend forecast remains 10.00 yen per share unchanged, indicating commitment to shareholder returns despite profit decline guidance.
Annual dividend forecast of 10.00 yen per share remains unchanged from prior year, maintaining dividend continuity despite projected net income decline. Based on full-year EPS forecast of 53.15 yen, the implied payout ratio is 18.8%, indicating conservative dividend policy with substantial retained earnings for reinvestment or balance sheet flexibility. At current net income of 39.6B yen for Q1 and forecast of 64.0B yen for full year, total annual dividends of approximately 12.0B yen (assuming 120.4M average shares) would represent a sustainable payout ratio of 18.8% with adequate cash coverage. No share buyback activity was disclosed for the quarter. The total return ratio remains equivalent to the payout ratio at 18.8% in the absence of buybacks, indicating the company prioritizes balance sheet preservation and internal investment over aggressive shareholder distributions. Given cash reserves of 300.0B yen and strong current ratio of 197.7%, dividend sustainability appears secure despite elevated short-term borrowings.
Segment concentration risk: Agricultural Chemicals and Agriculture-Related segment represents 80.9% of total revenue, creating vulnerability to agricultural market cycles, regulatory changes, climate volatility, and crop demand fluctuations. Any disruption in this core segment would materially impact consolidated performance, and the Q1 results show this concentration intensifying from 79.8% prior year.
Working capital deterioration risk: Inventories of 580.7B yen (representing 22.3% of total assets and 124.3% of quarterly revenue) combined with accounts receivable of 462.1B yen indicate extended cash conversion cycles and potential inventory obsolescence or demand softness. The implied inventory turnover and receivables collection efficiency have deteriorated substantially, constraining cash generation and requiring external financing.
Refinancing and liquidity risk: Short-term borrowings increased 36.6% to 502.5B yen, representing 79.4% of total interest-bearing debt and creating maturity concentration. With cash-to-short-term-debt coverage of only 0.60x, the company faces refinancing risk if credit conditions tighten or operational cash flow disappoints, despite maintaining adequate current ratio of 197.7%.
[Industry Position] (Reference - Proprietary Analysis)
Within the manufacturing industry peer group, the company demonstrates mixed competitive positioning. Profitability: Operating margin of 10.7% exceeds the industry median of 6.8% (IQR: 2.9%-9.0%, n=8), indicating superior operational efficiency and pricing power primarily driven by the core Agricultural Chemicals segment achieving 12.2% margin. Net profit margin of 8.5% also surpasses industry median of 5.9% (IQR: 3.3%-7.7%, n=8), reflecting strong bottom-line conversion despite elevated tax burden. Financial Health: Equity ratio of 59.1% substantially exceeds industry median of 43.9% (IQR: 28.4%-50.7%, n=8), demonstrating conservative capital structure and financial stability. Current ratio of 197.7% aligns with industry median of 187.0% (IQR: 186%-223%, n=3), confirming adequate short-term liquidity positioning. Efficiency: ROE of 2.6% falls below industry median of 3.1% (IQR: 2.0%-4.9%, n=8), highlighting capital efficiency challenges despite strong margins. Asset turnover of 0.179x approximates industry median of 0.17x (IQR: 0.16-0.23, n=8), though remains constrained by elevated inventory and investment securities balances. Revenue growth of 7.7% falls below industry median of 13.2% (IQR: 2.5%-28.5%, n=8), suggesting moderate top-line momentum relative to peers. The company ranks favorably on profitability metrics but lags on capital efficiency and growth rates, indicating opportunities for working capital optimization and accelerated expansion to enhance shareholder value relative to industry standards.
(Industry: Manufacturing sector (n=8 companies), Comparison: FY2025 Q1 peer data, Source: Proprietary analysis)
Strong operating leverage with margin expansion: The company demonstrated significant operating profit growth of +24.5% on revenue growth of +7.7%, driven by core Agricultural Chemicals segment margin expansion from 10.4% to 12.2%. Operating margin improved 1.5pt to 10.7%, substantially exceeding the industry median of 6.8%, indicating superior pricing power and operational efficiency in its dominant segment. This profitability trajectory represents a structural competitive advantage if sustained, though the aggressive full-year guidance implies significant sequential margin compression expected in subsequent quarters.
Capital efficiency and working capital challenges require strategic attention: Despite strong profitability, ROE remains suppressed at 2.6% due to low asset turnover of 0.179x, constrained by elevated inventories of 580.7B yen and investment securities of 409.4B yen representing 38% of total assets combined. The substantial working capital buildup in inventories (+8.1B yen) and receivables (+72.5B yen) alongside 36.6% increase in short-term borrowings to 502.5B yen signals cash conversion deterioration. The company's cash position growth to 300.0B yen appears debt-financed rather than organically generated, creating refinancing risk concentration with 79.4% of debt maturing short-term. Improvement in working capital efficiency and investment portfolio optimization would be key catalysts for enhanced capital returns.
Earnings quality considerations from equity method income dependency: Equity method income of 13.7B yen contributed 55% of non-operating income and 27.5% of ordinary income, representing significant earnings dependency on associated company performance rather than core operations. This 54.7% increase YoY in equity method gains materially supported the ordinary income growth of +23.4%, creating sustainability questions if associated company performance normalizes. The elevated effective tax rate of 36.2% versus prior year's 18.7% suggests normalization from previous benefits, indicating future net income conversion may face continued tax headwinds. The divergence between comprehensive income of 48.8B yen and net income of 39.6B yen reflects 23.2% unrealized gains primarily from equity securities and associated companies, highlighting valuation sensitivity to market conditions.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.